Table 2. Lesion and procedural characteristics.
| ABSORB EXTEND (n = 34) | BVS in real world (n = 38) | p value | |
| Vessels treated, n (%) | 0.57 | ||
| Left anterior descending | 12 (35.3) | 18 (47.4) | |
| Left circumflex | 9 (26.5) | 9 (23.7) | |
| Ramus | 1 (2.9) | 0 | |
| Right coronary artery | 12 (35.3) | 11 (28.9) | |
| AHA lesion typesa | 0.007 | ||
| A | 16 (47.1) | 20 (52.6) | |
| B1 | 18 (52.9) | 9 (23.7) | |
| B2 | 0 | 2 (5.3) | |
| C | 0 | 7 (18.4) | |
| Number of scaffold use | 37 | 49 | 0.14 |
| Scaffold diameter | 0.02 | ||
| 2.5 mm | 6 (17.6) | 6 (15.8) | |
| 3.0 mm | 22 (64.7) | 14 (36.8) | |
| 3.5 mm | 6 (17.6) | 18 (47.4) | |
| Total scaffold length per lesion, mm | 20.9 ± 6.1 | 30.3 ± 19.2 | 0.008 |
| Scaffold-scaffold overlap | 3 (8.8) | 8 (21.1) | 0.15 |
| Stent-scaffold overlap | 0 | 5 (13.2) | 0.03 |
| Chronic total occlusion lesion | 0 | 3 (7.9) | 0.09 |
| Pre-dilatation | 34 (100) | 37 (97.7) | 0.34 |
| Pre-dilatation max balloon size, mm | 2.88 ± 0.34 | 3.05 ± 0.39 | 0.96 |
| Pre-dilatation max inflation pressure, atm | 10.9 ± 2.1 | 11.3 ± 3.5 | 0.74 |
| BVS deployment pressure, atm | 11.8 ± 1.6 | 11.3 ± 2.1 | 0.14 |
| Post-dilatation | 34 (100) | 37 (97.7) | 0.34 |
| Post-dilatation max balloon size, mm | 3.02 ± 0.30 | 3.16 ± 0.43 | 0.94 |
| Post-dilatation max inflation pressure, atm | 17.9 ± 3.0 | 17.2 ± 4.2 | 0.22 |
| Balloon-scaffold ratio | 0.96 ± 0.07 | 0.97 ± 0.09 | 0.69 |
| Intravascular ultrasound | 0 | 9 (23.7) | 0.002 |
a Lesions were classified according to the modified American College of Cardiology/American Heart Association (ACC/AHA) grading system. BVS, bioresorbable vascular scaffold.